BTD rs397507172: Understanding Your Carrier Status
The rs397507172 variant is a rare genetic change located within the BTD gene. It is identified in clinical databases as a carrier variant associated with autosomal recessive biotinidase deficiency.
What each genotype means
Typical BTD genotype
This is the common, wild-type genotype for this position in the BTD gene. It is not associated with biotinidase deficiency.
This is the most common genotype found in the general population.
Carrier of biotinidase deficiency variant
You carry one copy of a variant associated with biotinidase deficiency. Because this condition is inherited in an autosomal recessive manner, carrying a single copy typically does not cause the disorder, but you may wish to discuss reproductive carrier screening with a genetic counselor.
This genotype is very rare, with the variant allele occurring at a frequency of less than 0.001 in global populations.
Potential biotinidase deficiency
This genotype indicates the presence of two copies of the variant, which is classified as pathogenic in clinical databases. This may be associated with biotinidase deficiency, a condition that can affect biotin metabolism; please consult with a medical professional or metabolic specialist to discuss clinical implications and testing.
This genotype is extremely rare in the general population.
What is the rs397507172 Variant?
The rs397507172 variant is a specific single nucleotide polymorphism (SNP) found within the BTD gene, which is located on chromosome 3. In genetics, a variant is a permanent change in the DNA sequence that makes up a gene. This particular variant is categorized as a carrier variant, meaning that individuals who possess it may carry one copy of a genetic change that, if inherited in pairs, could lead to a specific metabolic condition. Because this variant is very rare, it is not commonly found in the general population. Geneticists and researchers track such variants to better understand how they contribute to human health and to provide information for reproductive carrier screening programs, which help individuals understand their risk of passing certain conditions to their children.
The Role of the BTD Gene
The BTD gene provides the essential instructions for the body to produce an enzyme called biotinidase. This enzyme plays a critical role in recycling biotin, a B vitamin that is vital for various metabolic processes, including the breakdown of fats and carbohydrates. By cleaving biocytin—a byproduct of protein degradation—biotinidase allows the body to reuse biotin, ensuring that cells have a steady supply of this nutrient. When the BTD gene contains pathogenic variants that significantly reduce or eliminate the activity of this enzyme, the body cannot effectively recycle biotin. This leads to biotinidase deficiency, a condition that can cause a range of neurological and physical symptoms if not managed with appropriate biotin supplementation. The severity of the deficiency often depends on the specific nature of the genetic variants present.
Research and Clinical Evidence
Research into BTD variants is primarily focused on their role in biotinidase deficiency, an autosomal recessive disorder. This means that an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to manifest the condition. Carriers, who have only one copy, are generally asymptomatic. The evidence for many specific BTD variants, including rare ones like rs397507172, is often described as limited because they are not frequently observed in large clinical studies. While some common variants like D444H are well-documented, rarer variants require ongoing clinical observation to fully understand their impact on enzyme function. If you have received information about this variant through a carrier screening test, it is important to discuss the results with a genetic counselor or your healthcare provider, who can place the finding in the context of your overall health and family history.
Population Frequency and Interpretation
The rs397507172 variant is classified as very rare globally, with a minor allele frequency of less than 0.001 in major databases like gnomAD. Because it is so uncommon, it is not a variant that most people will encounter in their genetic reports. When interpreting such rare findings, it is essential to remember that carrier status does not mean you have the disease. It simply indicates that you carry a genetic instruction that could be relevant for family planning. Because the evidence for this specific variant is limited, it is not always possible to predict its exact effect on enzyme activity without further clinical testing. Always consult with a qualified medical professional to understand what these results mean for you and your family, and avoid making medical decisions based solely on raw genetic data.
How common is this variant?
The rs397507172 variant is extremely rare, with a minor allele frequency of less than 0.001 across global populations in gnomAD.
Frequently asked questions
What is biotinidase deficiency?
Biotinidase deficiency is an inherited metabolic disorder where the body cannot recycle the vitamin biotin. If untreated, it can lead to neurological and physical symptoms, but it is often managed effectively with biotin supplements.
Does being a carrier mean I have the disease?
No, being a carrier of an autosomal recessive condition like biotinidase deficiency typically means you have one copy of a variant and one normal copy of the gene. Carriers are generally asymptomatic and do not have the condition.
What should I do if I am a carrier?
If you are identified as a carrier, you should discuss the results with a genetic counselor or your doctor. They can help you understand the implications for your health and provide guidance on family planning and testing for your partner.
Is this variant common?
No, rs397507172 is considered very rare. It is not a common variant found in the general population.
Sources & further reading
Educational information only, last refreshed 9/22/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs397507172?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BTD
Carrier variant indicating predisposition to pass on autosomal recessive biotinidase deficiency.
Pathogenic variant in the BTD gene associated with biotinidase deficiency, an autosomal recessive metabolic disorder.
This variant is linked to biotinidase deficiency, where heterozygous carriers may be identified through clinical screening.
This variant is identified as a carrier mutation for biotinidase deficiency.
This variant is a known carrier mutation for biotinidase deficiency.
This variant is associated with carrier status for biotinidase deficiency.